Nothing Special   »   [go: up one dir, main page]

AU2001292705A1 - Method of treating gastrointestinal disorders, particularly colitis - Google Patents

Method of treating gastrointestinal disorders, particularly colitis

Info

Publication number
AU2001292705A1
AU2001292705A1 AU2001292705A AU9270501A AU2001292705A1 AU 2001292705 A1 AU2001292705 A1 AU 2001292705A1 AU 2001292705 A AU2001292705 A AU 2001292705A AU 9270501 A AU9270501 A AU 9270501A AU 2001292705 A1 AU2001292705 A1 AU 2001292705A1
Authority
AU
Australia
Prior art keywords
gastrointestinal disorders
treating gastrointestinal
colitis
particularly colitis
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001292705A
Inventor
Robert W. Harkins
Harry Mazurek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lyondell Chemical Technology LP
Original Assignee
Arco Chemical Technology LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arco Chemical Technology LP filed Critical Arco Chemical Technology LP
Publication of AU2001292705A1 publication Critical patent/AU2001292705A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/25—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
    • C07C69/30—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with trihydroxylic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001292705A 2000-09-19 2001-09-18 Method of treating gastrointestinal disorders, particularly colitis Abandoned AU2001292705A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/664,172 US6387952B1 (en) 2000-09-19 2000-09-19 Method of treating gastrointestinal disorders, particularly colitis
US09664172 2000-09-19
PCT/US2001/029006 WO2002024195A1 (en) 2000-09-19 2001-09-18 Method of treating gastrointestinal disorders, particularly colitis

Publications (1)

Publication Number Publication Date
AU2001292705A1 true AU2001292705A1 (en) 2002-04-02

Family

ID=24664874

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001292705A Abandoned AU2001292705A1 (en) 2000-09-19 2001-09-18 Method of treating gastrointestinal disorders, particularly colitis

Country Status (3)

Country Link
US (1) US6387952B1 (en)
AU (1) AU2001292705A1 (en)
WO (1) WO2002024195A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1642885B1 (en) 2000-08-29 2009-11-11 Biocon Limited Use of a pharmaceutical composition containing a para-aminophenyl acetic acid derivative for treating inflammatory conditions of the gastrointestinal tract
US8048924B2 (en) * 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
US20030118329A1 (en) * 2001-12-21 2003-06-26 Pere Obrador Video indexing using high resolution still images
US20050070603A1 (en) * 2003-09-25 2005-03-31 Shah Praful K. Use of glycerides to alleviate symptoms of digestive disorders
CA2553775A1 (en) * 2004-01-20 2005-08-11 Richard F. Harty Compositions and methods of treatment for inflammatory diseases
WO2006014549A2 (en) 2004-07-07 2006-02-09 Nobex Corporation Synthesis of azo bonded immunoregulatory compounds
GB201215289D0 (en) 2012-08-28 2012-10-10 Medical Res Council Nanoparticle formulation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861613A (en) * 1986-07-25 1989-08-29 Arco Chemical Technology, Inc. Non-digestible fat substitutes of low-caloric value
US5175323A (en) 1988-08-01 1992-12-29 Arco Chemical Technology, L.P. Preparation of esterified propoxylated glycerin by transesterification
US4983329A (en) * 1988-08-26 1991-01-08 Arco Chemical Technology, Inc. Preparation of esterified propoxylated glycerin from free fatty acids
AU645070B2 (en) * 1990-04-10 1994-01-06 Nb International Technologies Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients DO NOT SEAL - SEE LETTER DATED 22.03.94
US5298637A (en) * 1992-10-22 1994-03-29 Arco Chemical Technology, L.P. Process for producing a reduced calorie lipid composition
US5399728A (en) * 1993-04-05 1995-03-21 Arco Chemical Technology, L.P. Process for the preparation of highly esterified alkoxylated polyol compositions
US5399729A (en) * 1993-08-31 1995-03-21 Arco Chemical Technology, L.P. Esterified alkoxylated polyol fat substitutes having high primary ester content
DE69510749T2 (en) 1994-10-21 1999-12-02 Arco Chemical Technology, L.P. Process for the preparation of propoxylated glycerol esterified by fatty acids
US5569680A (en) 1995-02-13 1996-10-29 Trustees Of The Univ. Of Penna Method of treating inflammatory bowel disease with tributyrin

Also Published As

Publication number Publication date
US6387952B1 (en) 2002-05-14
WO2002024195A1 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
AU2002215125A1 (en) Well treatment method
AU2001260513A1 (en) Microcapsule well treatment
AU2002348135A1 (en) Methods for the treatment of addiction
EP1419218A4 (en) Continuous naphtha treatment method
AU2002223827A1 (en) Well treatment
AU2002257936A1 (en) Methods of well treatment
ZA200108446B (en) Novel method of treatment.
AU2001239858A1 (en) Wastewater treatment process
GB0129976D0 (en) Treatment method
HK1064261A1 (en) Method for the treatment of tobacco.
AU2001285747A1 (en) Method for the treatment of tobacco
MXPA03006607A (en) Combined method for treating hormono-dependent disorders.
AP2004003070A0 (en) The method of treating cancer.
AU2001292705A1 (en) Method of treating gastrointestinal disorders, particularly colitis
GB0120147D0 (en) Treatment method
AU6726700A (en) Method of treating 1,1,1,3,3-pentafluoropropane
MXPA03004017A (en) Method for the treatment of inflammation.
AU2002357591A1 (en) Substrate treating method
AU2001262177A1 (en) Method of treatment
AUPR731901A0 (en) Method of treatment
AU2001236909A1 (en) Method of treating disorders of the eye
GB0126253D0 (en) Treatment method
AU2002329587A1 (en) Method for the treatment of atopic dermatitis
AU2002229796A1 (en) Method for treating sleep disorders
AU2002331778A1 (en) Treatment of atopic dermatitis